About Test
Introducing Testology's Male Cancer Panel Extended—a comprehensive diagnostic solution meticulously crafted to assess key biomarkers associated with male-specific cancers. Our panel includes an extensive array of tests, covering essential markers such as PSA (Prostate-Specific Antigen), both Free and Total forms, CA 19-9, CEA (Carcinoembryonic Antigen), AFP (Alpha-Fetoprotein), and HCG (Human Chorionic Gonadotropin), providing valuable insights into prostate, colorectal, liver, and other cancer risks in men.
PSA testing aids in the early detection of prostate cancer, while CA 19-9 serves as a marker for various cancers, including pancreatic and gastrointestinal cancers. Additionally, CEA, AFP, and HCG testing are vital for monitoring colorectal, liver, and testicular cancers respectively, enabling proactive management and timely intervention.
With precise testing for these biomarkers, our Male Cancer Panel Extended empowers early detection and proactive management of cancer risks specific to men. At Testology, we prioritize accuracy, confidentiality, and convenience, ensuring that your test results are delivered with precision and discretion.
Trust Testology to be your partner in promoting proactive health management and early detection of male-specific cancers. Take control of your health with Testology's Male Cancer Panel Extended, and gain peace of mind knowing that you're prioritizing your well-being.
​
Male Cancer Panel Extended includes the following:
​
-
PSA, Free & Total
-
CA 19-9
-
CEA
-
AFP, Tumor Marker
-
HCG, Tumor Marker
To view panel description click here